Qube Research & Technologies LTD Anika Therapeutics, Inc. Transaction History
Qube Research & Technologies LTD
- $65.7 Billion
- Q3 2024
A detailed history of Qube Research & Technologies LTD transactions in Anika Therapeutics, Inc. stock. As of the latest transaction made, Qube Research & Technologies LTD holds 25,925 shares of ANIK stock, worth $451,872. This represents 0.0% of its overall portfolio holdings.
Number of Shares
25,925
Previous 7,986
224.63%
Holding current value
$451,872
Previous $202,000
216.83%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding ANIK
# of Institutions
123Shares Held
11.5MCall Options Held
200Put Options Held
100-
Trigran Investments, Inc.2.12MShares$37 Million5.75% of portfolio
-
Black Rock Inc. New York, NY1.61MShares$28 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA799KShares$13.9 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX707KShares$12.3 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny574KShares$10 Million0.02% of portfolio
About Anika Therapeutics, Inc.
- Ticker ANIK
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 14,599,900
- Market Cap $254M
- Description
- Anika Therapeutics, Inc., a joint preservation company, creates and delivers advancements in early intervention orthopedic care in the areas of osteoarthritis (OA) pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies in the United States, Europe, and internationally. The company develops, manufactur...